OpenVSafe by OpenVAERS
Search V-safe

YRD-87129-70741

2 vaccinations 7 coded responses 15 check-ins 7 free-text entries 8 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
802 / CO
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Gait disturbance, Limb discomfort — Feeling: Good · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Left leg , lower half seems very heavy , I am walking awkwardly. Having to think to lift my foot . I think foot drop?
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Gait disturbance, Limb discomfort, Muscular weakness — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Right leg is weak and awkward when walking , and walking slower than normal . My left feels heavy and I have to consciously lift my foot walk
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-24
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Muscular weakness, Myalgia — Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Weakness in right lower leg , muscle pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2020-12-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Muscle or body aches
    Adult check-in
  12. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Poor · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  13. 2020-12-29
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  15. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches
    Adult check-in
  16. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-01-27
    Health check-in — day 14, dose 2
    Feeling: Poor
    Adult check-in
  18. 2021-02-01
    Survey response — day 21, dose 2
    MedDRA: Muscular weakness, Neck pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Weakness in both arms and hands , neck pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-01
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-02-10
    Survey response — day 28, dose 2
    MedDRA: Muscular weakness, Office visit, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: More weakening of right arm , saw neurologist had mri · Healthcare visit (other): Mri
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-10
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-02-24
    Survey response — day 42, dose 2
    MedDRA: Asthenia, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Muscle pain and weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-24
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-05-29
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  25. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  26. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-11
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  28. 2022-01-12

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2020-12-23 priority 2/3
2020-12-24 priority 2/3
2020-12-26 priority 2/3
2020-12-29 priority 2/3
2021-02-01 Successful
2021-05-29
Reported to VAERS voluntarily prior to GDIT contact
2021-02-10 Successful Reported to VAERS voluntarily prior to GDIT contact
2021-02-24 Successful Reported to VAERS voluntarily prior to GDIT contact
2022-01-11 Unsuccessful Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-23

Systemic reaction (other): Left leg , lower half seems very heavy , I am walking awkwardly. Having to think to lift my foot . I think foot drop?

2020-12-24

Systemic reaction (other): Right leg is weak and awkward when walking , and walking slower than normal . My left feels heavy and I have to consciously lift my foot walk

2020-12-26

Systemic reaction (other): Weakness in right lower leg , muscle pain

Release 3 — day 21, dose 2

2021-02-01

Symptoms: Weakness in both arms and hands , neck pain

Release 4 — day 28, dose 2

2021-02-10

Symptoms: More weakening of right arm , saw neurologist had mri
Healthcare visit (other): Mri

Release 4 — day 42, dose 2

2021-02-24

Symptoms: Muscle pain and weakness

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDNeck pain ✓ ✓ ✓
SDOffice visit ✓ ✓ ✓
SDRespiratory syncytial virus infection · · ✓
SROGait disturbance ✓ ✓ ✓
SROLimb discomfort ✓ ✓ ✓
SROMuscular weakness ✓ ✓ ✓
SROMyalgia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release